Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock [Yahoo! Finance]
Vaxxinity, Inc. (VAXX)
Company Research
Source: Yahoo! Finance
pioneering the development of a new class of medicines, today announced its intention to voluntarily delist from the Nasdaq Global Market (“Nasdaq”) and to deregister its Class A common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and suspend its reporting obligations under Section 15(d) of the Exchange Act. On February 9, 2024, the Company received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC indicating that the Company was no longer in compliance with Listing Rule 5450(a)(1) with respect to its Class A common stock, which requires the Company to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, and providing until August 7, 2024 to regain compliance. In determining to voluntarily delist and deregister its Class A common stock, the Company considered that the current low trading value, and the resulting low trading volume, limits the liquidity
Show less
Read more
Impact Snapshot
Event Time:
VAXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VAXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VAXX alerts
High impacting Vaxxinity, Inc. news events
Weekly update
A roundup of the hottest topics
VAXX
News
- Vaxxinity Issues Shareholder Letter [Yahoo! Finance]Yahoo! Finance
- Vaxxinity Issues Shareholder LetterGlobeNewswire
- Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common StockGlobeNewswire
- Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual MeetingGlobeNewswire
VAXX
Earnings
- 3/27/24 - Beat
VAXX
Sec Filings
- 5/3/24 - Form EFFECT
- 4/30/24 - Form S-8
- 4/30/24 - Form S-8
- VAXX's page on the SEC website